Future of Antigenic Immune Modulation

The markets are changing rapidly, tech is advancing fast, & we're all wondering what will be the next trends in #lifescience #investments. Come & join us, to hear from top #Healthcare #investors @Anglonordic - anglonordiclifescience.com

A big thank you to everyone who made #BioTrinity a success including all our sponsors, speakers, exhibitors, suppliers and partners, the @OBN_UK events team, and of course to all the delegates who attended the physical event over the last two days.

Nara Daubeney, COO/Co-Founder of @phaimpharma talking about alternatives for autoimmune diseases such as type 1 diabetes at #BioTrinity. What is the relevance for #RareDiseases? AIM therapy can potentially reset the balance for many autoimmune diseases.

The #biotechnology Presenting Companies have been announced for the upcoming @Anglonordic #lifescience Conference anglonordiclifescience.com/page/programme - on Thursday 5th May! Includes: @BiohopeS @bitbio @InProTher @leadartis @MediSieve @outruntx @ParasBiopharma @phaimpharma @Scandion

#biotrinity2016 @BRAINCURES: '@OBN_UK @biotrinity 2022: Catalysing Growth in the Life Sciences Industry Company w/ presentations from Vacmedix Grey Wolf Therapeutics Kargenera Argonaut Cumulus Oncology Epsilogen Antikor… , see more tweetedtimes.com/v/11483?s=tnp

Thank you @phaimpharma, @FineTreatment, and Prismea for introducing yourselves at this evening's @OBN_UK Science Social. Really interesting quickfire presentations! Find out more about these companies below: phaim.co.uk finetreatment.com prismea.com

OBN would like to welcome another couple of new Members today - we look forward to working with you and seeing you at our events soon @phaimpharma and @intellin_